Our data indicated that the expression of CORO1A and ANXA5 are significantly associated with multiple clinic-pathological features of breast cancer, such as age, menopause status, disease stage, nodal metastasis status, and molecular subtypes. Here, ANXA5 is linked to breast cancer.